Literature DB >> 3151063

Anti-mu antibody blocks LPS driven B cell differentiation by suppressing specific mRNAs.

R E Flahart1, A R Lawton.   

Abstract

High concentrations of anti-mu antibodies inhibit differentiation and increase proliferation of adult mouse splenic B cells stimulated by LPS. Cells from treated cultures express Ia antigens and on removal of anti-mu reexpress membrane IgM. They do not develop into plasmablasts secreting IgM. To investigate the mechanism of suppression we used Northern blots hybridized with cDNA probes to mu, kappa, J, and I-A beta chains to analyze RNAs in anti-mu suppressed and control cultures. Messenger RNAs for mu, kappa, and J chains but not I-A beta chain are diminished in anti-mu treated cells as compared to controls. Cells treated with anti-kappa antibodies have decreased mRNA levels for mu as well as kappa chains. Suppression mediated by modulation of the IgM receptor is not immunologically specific, but selectively inhibits expression of a cluster of unlinked genes which are coordinately activated during differentiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3151063

Source DB:  PubMed          Journal:  J Mol Cell Immunol        ISSN: 0724-6803


  3 in total

1.  Lipopolysaccharide-induced IgM production is not suppressed by antigen receptor ligation in B cells from some autoimmune strains of mice.

Authors:  C C Anderson; R Rahimpour; N R Sinclair
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

2.  Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution.

Authors:  A Marcuzzi; B Van Ness; T Rouse; D Lafrenz
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

3.  Mechanism of suppression of lipopolysaccharide-driven B cell differentiation by anti-mu antibodies. Evidence for a trans-acting repressor of transcription.

Authors:  R E Flahart; A R Lawton
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.